Mark A. Lemmon

34.2k citations
159 papers · 25.5k indexed · 8 hit papers · h-index 78

Mark A. Lemmon

156 papers receiving 25.1k citations

Hit Papers

The EGFR Family: Not So Prototy...343199420262004201510002.0k3.0k4.0k

Peers

Mark A. Lemmon
Comparison fields: 5 of 149
  • Cell Biology 7.1k
  • Molecular Biology 18.3k
  • Oncology 5.7k
  • Immunology and Allergy 1.2k
  • Radiology, Nuclear Medicine and Imaging 3.4k
Replace Pier Paolo Di Fiore with:
Pier Paolo Di Fiore Italy
Mark C. Willingham United States
Richard A. Cerione United States
Michael D. Waterfield United Kingdom
Peter J. Parker United Kingdom
Jonathan A. Cooper United States
Kevan M. Shokat United States
Susan S. Taylor United States
Kermit L. Carraway United States
A. Ullrich Germany
Mark A. Lemmon relative to Pier Paolo Di Fiore Italy Pier Paolo Di Fiore's profile →
Citations per field
00.5×1.5×2.1×
Pier Paolo Di Fiore · 1×
Citations per year

Countries citing papers authored by Mark A. Lemmon

Since Specialization
Citations

This map shows the geographic impact of Mark A. Lemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Lemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Lemmon more than expected).

Fields of papers citing papers by Mark A. Lemmon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Lemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Lemmon. The network helps show where Mark A. Lemmon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark A. Lemmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark A. Lemmon Line = papers co-authored together Mark A. Lemmon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202323
3 202216
4 202116
5 20198
6 201938
7 201815
8 201681
9 2015116
10 201491
11 2013112
12 201128
13 201144
14 2010366
15 2010128
16 200664
17 200696
18 200534
19 2003463
20 199989

About Mark A. Lemmon

Mark A. Lemmon is a scholar working on Immunology and Allergy, Cell Biology, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 159 papers that have together received 25.5k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (43 papers), Cellular transport and secretion (39 papers), Protein Kinase Regulation and GTPase Signaling (36 papers), Monoclonal and Polyclonal Antibodies Research (34 papers), Glycosylation and Glycoproteins Research (19 papers), Cell Adhesion Molecules Research (17 papers), Lipid Membrane Structure and Behavior (16 papers) and PI3K/AKT/mTOR signaling in cancer (13 papers). The work is most often cited by research in Cell Biology (7.1k citations), Molecular Biology (18.3k citations), Oncology (5.7k citations), Immunology and Allergy (1.2k citations) and Radiology, Nuclear Medicine and Imaging (3.4k citations). Mark A. Lemmon has collaborated with scholars based in United States, United Kingdom and Russia. Frequent co-authors include Joseph Schlessinger, Kathryn M. Ferguson, Donald M. Engelman, Jeannine M. Mendrola, Irit Lax, Mitchell B. Berger, Paul B. Sigler, Daryl E. Klein, Daniel J. Leahy and Ravi Radhakrishnan. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Cell, Biochemical Journal and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026